Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
EVOME MEDICAL TECHNOLOGIES INC. incurred guarantee with Pathward, National Association.
- Instrument
- guarantee
- Counterparty
- Pathward, National Association
- Event
- incurrence
Exact text from the filing
(“Borrower”), entered into a Master Credit and Security Agreement and related Schedule with Pathward, National Association (“Lender”) to receive financing accommodations in the form of a secured revolving loan of up to $3.0 million (the "Agreement"), of which approximately US $1.7 million was available to be borrowed as of September 12, 2023.
View on SEC.gov
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
EVOME MEDICAL TECHNOLOGIES INC. incurred revolving credit of up to $3.0 million with Pathward, National Association at the greater of 6.00% per annum or 0.75% in excess of the rate shown in the Wall.
- Instrument
- revolving credit
- Principal
- up to $3.0 million
- Counterparty
- Pathward, National Association
- Rate
- the greater of 6.00% per annum or 0.75% in excess of the rate shown in the Wall
- Event
- incurrence
Exact text from the filing
On September 12, 2023, an operating subsidiary of Salona Global Medical Device Corporation (“Company”), Biodex Medical Systems, Inc. (“Borrower”), entered into a Master Credit and Security Agreement and related Schedule with Pathward, National Association (“Lender”) to receive financing accommodations in the form of a secured revolving loan of up to $3.0 million (the "Agreement"), of which approximately US $1.7 million was available to be borrowed as of September 12, 2023.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
EVOME MEDICAL TECHNOLOGIES INC. entered into Master Credit and Security Agreement with Pathward, National Association valued at up to $3.0 million (effective 2023-09-12).
- Action
- entry
- Agreement
- credit facility
- Counterparty
- Pathward, National Association
- Value
- up to $3.0 million
- Effective
- 2023-09-12
Exact text from the filing
On September 12, 2023, an operating subsidiary of Salona Global Medical Device Corporation (“Company”), Biodex Medical Systems, Inc. (“Borrower”), entered into a Master Credit and Security Agreement and related Schedule with Pathward, National Association (“Lender”) to receive financing accommodations in the form of a secured revolving loan of up to $3.0 million (the "Agreement")
View on SEC.gov